XML 44 R35.htm IDEA: XBRL DOCUMENT v3.22.1
Theravance Respiratory Company, LLC - Summary financial information (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Summary financial information      
Current assets $ 204,636   $ 249,870
Current liabilities 44,201   $ 58,587
Revenues 13,196 $ 14,257  
Net income (25,946) (79,679)  
TRC      
Summary financial information      
Income from continuing operations 29,112 18,803  
Net income $ 29,541 18,320  
Percentage of equity interest 85.00%    
TRC | Royalties      
Summary financial information      
Revenues $ 29,309 $ 22,084